Articolo in rivista, 2023, ENG, 10.3390/cells12202448

Liposome-Mediated Delivery Improves the Efficacy of Lisosan G against Retinopathy in Diabetic Mice

Amato R., Melecchi A., Pucci L., Canovai A., Marracci S., Cammalleri M., Dal Monte M., Caddeo C., Casini G.

Department of Biology, University of Pisa, Pisa, 56126, Italy Institute of Agricultural Biology and Biotechnology, National Research Council (CNR), Pisa, 56124, Italy Interdepartmental Research Center Nutrafood "Nutraceuticals and Food for Health", University of Pisa, Pisa, 56124, Italy Department of Life and Environmental Sciences, University of Cagliari, Cagliari, 09042, Italy

Nutraceuticals are natural substances whose anti-oxidant and anti-inflammatory properties may be used to treat retinal pathologies. Their efficacy is limited by poor bioavailability, which could be improved using nanocarriers. Lisosan G (LG), a fermented powder from whole grains, protects the retina from diabetic retinopathy (DR)-induced damage. For this study, we tested whether the encapsulation of LG in liposomes (LipoLG) may increase its protective effects. Diabetes was induced in mice via streptozotocin administration, and the mice were allowed to freely drink water or a water dispersion of two different doses of LG or of LipoLG. Electroretinographic recordings after 6 weeks showed that only the highest dose of LG could partially protect the retina from diabetes-induced functional deficits, while both doses of LipoLG were effective. An evaluation of molecular markers of oxidative stress, inflammation, apoptosis, vascular endothelial growth factor, and the blood-retinal barrier confirmed that the highest dose of LG only partially protected the retina from DR-induced changes, while virtually complete prevention was obtained with either dose of LipoLG. These data indicate that the efficacy of LG in contrasting DR is greatly enhanced by its encapsulation in liposomes and may lay the ground for new dietary supplements with improved therapeutic effects against DR.

Cells

Keywords

nutraceutical, bioavailability;, nanocarriers, diabetic retinopathy, electroretinography, oxidative stress, inflammation, blood-retinal barrier

CNR authors

Pucci Laura

CNR institutes

IBBA – Istituto di biologia e biotecnologia agraria

ID: 489530

Year: 2023

Type: Articolo in rivista

Creation: 2023-12-06 16:16:47.000

Last update: 2023-12-17 09:07:02.000

CNR authors

External links

OAI-PMH: Dublin Core

OAI-PMH: Mods

OAI-PMH: RDF

DOI: 10.3390/cells12202448

External IDs

CNR OAI-PMH: oai:it.cnr:prodotti:489530

DOI: 10.3390/cells12202448